Physician profile
Jay Schapira
NPI 1932218666
$1,420.72
in general payments reported to CMS, 2019-2025
15 companies · $425 in 2025
The $425 reported for 2025 was less than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $369 · 2020: $427 · 2021: $18.49 · 2023: $27.97 · 2024: $153 · 2025: $425.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $606.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $605.79 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Welch Allyn | $382.47 | 2020 | |
| Novartis Pharmaceuticals Corporation | $203.72 | 2019-2025 | |
| Medtronic, INC. | $168.00 | 2025 | Symplicity G3 |
| Abbott Laboratories | $167.03 | 2019 | |
| Boston Scientific Corporation | $130.59 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $114.55 | 2025 | Camzyos |
| Pfizer INC. | $65.81 | 2023-2024 | |
| Mallinckrodt Hospital Products INC. | $30.53 | 2024 | Terlivaz |
| Regeneron Healthcare Solutions, INC. | $29.39 | 2019 | |
| Dexcom, INC. | $28.69 | 2025 | Dexcom G6 Transmitter |
| Amgen INC. | $24.50 | 2025 | Repatha |
| Medtronic Vascular, INC. | $21.15 | 2020 | |
| Abbvie INC. | $18.49 | 2021 | |
| Cathworks, INC. | $18.40 | 2019 | |
| Shockwave Medical, INC | $17.40 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jay Schapira listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.